Laser patterned microcoagulation (LPM) in the management of desquamative gingivitis secondary to oral lichen planus: A randomized controlled pilot clinical trial (LPM TRIAL)
- PMID: 40214823
- DOI: 10.1007/s10103-025-04454-3
Laser patterned microcoagulation (LPM) in the management of desquamative gingivitis secondary to oral lichen planus: A randomized controlled pilot clinical trial (LPM TRIAL)
Abstract
The application of laser patterned microcoagulation (LPM) for the management of desquamative gingivitis secondary to oral lichen planus (OLP) was investigated. This single-centre, randomized, sham-controlled, single-blinded, parallel-arm pilot clinical trial included 30 patients diagnosed with OLP manifesting only as desquamative gingivitis. Permuted block randomization was performed. LPM was performed in the test group and sham treatment was provided to the control group along with 0.1% triamcinolone acetonide application. Diode laser with 940nm wavelength with a tip diameter of 400μm and power 0.5 W was utilized in pulsed contact mode for 250 ms to induce thermal injury zones. Five joules of energy were delivered at a fluence of 4kJ/Cm2 at the tip. LPM led to a significant reduction in the number and size of gingival lesions in the test group. Compared to the control group (4.07 ± 0.80), pain reduction was significant in the test group (6.4 ± 0.51, p = 0.000). Oral diseases severity score for pain at three months in test group (1.87 ± 0.64) was significantly lesser than in control (2.47 ± 0.64, p = 0.021) and Thongprasom's score at six months was 0.33 ± 0.49 in test and 1.33 ± 0.49 in control group (p = 0.000). LPM was well-tolerated by all patients, with no significant adverse effects. This study provides evidence of the effectiveness and safety of LPM as a novel treatment modality for the management of desquamative lesions of OLP suggesting accelerated healing and reduced inflammation.
Keywords: Gingiva; Gingival diseases; LASER; Lichen planus.
© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.
Conflict of interest statement
Declarations. Competing interest: The authors declare no competing interests. Human ethics and consent to participate declarations: It is declared that this study obtained institutional ethical clearance from Institutional Ethical Committee of Army Dental Centre (Research & Referral), New Delhi, India and prospectively registered with Clinical Trials Registry of India. All the participants of this study provided written informed consent to participate in this clinical trial.
Similar articles
-
Chlorhexidine mouthrinse as an adjunctive treatment for gingival health.Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD008676. doi: 10.1002/14651858.CD008676.pub2. Cochrane Database Syst Rev. 2017. PMID: 28362061 Free PMC article.
-
Interventions for erosive lichen planus affecting mucosal sites.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008092. doi: 10.1002/14651858.CD008092.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336835 Free PMC article.
-
Interventions for treating oral lichen planus.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD001168. doi: 10.1002/14651858.CD001168.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2020 Feb 28;2:CD001168. doi: 10.1002/14651858.CD001168.pub3. PMID: 21735381 Updated.
-
Efficacy of low-level laser therapy compared to steroid therapy in the treatment of oral lichen planus: A systematic review.J Oral Pathol Med. 2018 Jan;47(1):11-17. doi: 10.1111/jop.12619. Epub 2017 Aug 21. J Oral Pathol Med. 2018. PMID: 28766756
-
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD007419. doi: 10.1002/14651858.CD007419.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Oct 16;10:CD007419. doi: 10.1002/14651858.CD007419.pub6. PMID: 28639415 Free PMC article. Updated.
References
-
- Chapple ILC, Mealey BL, Van Dyke TE et al (2018) Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 89(Suppl 1):S74–S84. https://doi.org/10.1002/JPER.17-0719 - DOI - PubMed
-
- Agha-Hosseini F, Moosavi MS, Bahrami H (2023) A systematic review of interleukin-17 in oral lichen planus: from etiopathogenesis to treatment. Clin Med Res 21(4):201–215. https://doi.org/10.3121/cmr.2023.1822.PMID:38296640;PMCID:PMC11149959 - DOI - PubMed - PMC
-
- Chancellor MB (2024) Rationale for the use of topical calcineurin inhibitors in the management of oral lichen planus and mucosal inflammatory diseases. Cureus. 16(11):e74570. https://doi.org/10.7759/cureus.74570 . (Published 2024 Nov 27) - DOI - PubMed - PMC
-
- Sciuca AM, Toader MP, Stelea CG et al (2022) Desquamative gingivitis in the context of autoimmune bullous dermatoses and lichen planus-Challenges in the diagnosis and treatment. Diagnostics (Basel). 12(7):1754. https://doi.org/10.3390/diagnostics12071754 . (Published 2022 Jul 20) - DOI - PubMed - PMC
-
- Lipko NB (2022) Photobiomodulation: evolution and adaptation. PhotobiomodulPhotomed Laser Surg 40(4):213–233. https://doi.org/10.1089/photob.2021.0145 - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources